Tevogen Bio Holdings Inc. (TVGN) P/E Ratio History
Historical price-to-earnings valuation from 2022 to 2022
Loading P/E history...
TVGN Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Tevogen Bio Holdings Inc. (TVGN) trades at a price-to-earnings ratio of -79.9x, with a stock price of $7.48 and trailing twelve-month earnings per share of $-0.16.
The current P/E is 101% below its 5-year average of 9668.2x. Over the past five years, TVGN's P/E has ranged from a low of 5620.2x to a high of 13716.2x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Healthcare sector median P/E of 22.3x, TVGN trades at a 458% discount to its sector peers. The sector includes 241 companies with P/E ratios ranging from 0.0x to 177.5x.
Relative to the broader market, TVGN trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our TVGN DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
TVGN P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $7B | 15.5 | -Best | +1747%Best | |
| $2B | 14.1 | -Best | -26% | |
| $2B | 3.6Lowest | -Best | +307% | |
| $178M | 10.6 | -Best | +150% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
TVGN Historical P/E Data (2022–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q4 | Sat Dec 31 2022 00:00:00 GM | $516.50 | $0.09 | 5620.2x | -42% |
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $507.50 | $0.04 | 13716.2x | +42% |
Average P/E for displayed period: 9668.2x
See TVGN's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs TVGN Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare TVGN vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonTVGN — Frequently Asked Questions
Quick answers to the most common questions about buying TVGN stock.
Is TVGN stock overvalued or undervalued?
TVGN trades at -79.9x P/E, below its 5-year average of 9668.2x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does TVGN's valuation compare to peers?
Tevogen Bio Holdings Inc. P/E of -79.9x compares to sector median of 22.3x. The discount suggests lower growth expectations or higher risk.
What is TVGN's PEG ratio?
TVGN PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2022-2022.